Molecular immunology is a specialized field within immunology that delves into the molecular mechanisms underlying the immune system's functions. It explores how genes, proteins, and signaling pathways contribute to immune responses, including the recognition and elimination of pathogens, maintenance of immune tolerance, and development of immunological memory. Key areas of research in molecular immunology include the study of antigen processing and presentation, T and B cell receptor signaling, cytokine signaling pathways, and the regulation of immune cell development and differentiation. Understanding the molecular basis of immune responses is crucial for unraveling the complexities of various diseases, including autoimmune disorders, allergies, and immunodeficiencies. Advancements in molecular biology techniques, such as genomics and proteomics, have significantly contributed to the progress in molecular immunology. This field's insights have practical applications in vaccine development, immunotherapy, and the design of targeted interventions for immune-related diseases. Ongoing research continues to uncover the intricate molecular networks governing immune function, providing a foundation for innovative approaches to modulate the immune system for therapeutic purposes.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States